Mesenchymal stem cell immunomodulation and regeneration therapeutics as an ameliorative approach for COVID-19 pandemics

The severe acute respiratory syndrome-novel coronavirus mediated COVID-19 has been recently declared a pandemic by the World Health Organization. The primary target of the SARS-CoV-2 virus is the human lungs governed by the ACE-2 receptor of epithelial type II cells/endothelial cells, which promote...

Descripción completa

Detalles Bibliográficos
Autores principales: Yadav, Pooja, Vats, Ravina, Bano, Afsareen, Bhardwaj, Rashmi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2020
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7547615/
https://www.ncbi.nlm.nih.gov/pubmed/33049279
http://dx.doi.org/10.1016/j.lfs.2020.118588

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7547615/
https://www.ncbi.nlm.nih.gov/pubmed/33049279
http://dx.doi.org/10.1016/j.lfs.2020.118588

Ejemplares similares